Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 25.84% is in line with its 5-year average of 26.70%, near the low end of its 5-year range (21.24%–42.10%).
As of the fiscal period ended Tuesday, June 30, 2026. 11.38% below its 12-month average of 29.16%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 25.84%.
DEBT TO ASSETS RATIO
25.84%
DEBT TO ASSETS RATIO AVG TTM
29.16%
DEBT TO ASSETS RATIO AVG 3Y
28.73%
DEBT TO ASSETS RATIO AVG 5Y
26.70%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-11.38%
CURRENT VS 3Y AVG
-10.07%
CURRENT VS 5Y AVG
-3.22%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 643 covered companies
CURRENT VS SECTOR MEDIAN
+25739.73%
vs the sector median at left
Alignment Healthcare, Inc.
Market Cap
$1.74B
Debt to Assets Ratio
25.84%
TTM Avg
29.16%
3Y Avg
28.73%
5Y Avg
26.70%
Market Cap
$1.72B
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.72B
Debt to Assets Ratio
0.44%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.78B
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.64B
Debt to Assets Ratio
0.76%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.62B
Debt to Assets Ratio
0.22%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.62B
Debt to Assets Ratio
0.22%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.82B
Debt to Assets Ratio
0.30%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alignment Healthcare, Inc. (ALHC) | $1.74B | 25.84% | 29.16% | 28.73% | 26.70% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.72B | 0.09% | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.72B | 0.44% | N/A | N/A | N/A |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | 0.11% | N/A | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.64B | 0.76% | N/A | N/A | N/A |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.62B | 0.22% | N/A | N/A | N/A |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.62B | 0.22% | N/A | N/A | N/A |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 0.30% | N/A | N/A | N/A |
| Absci Corporation (ABSI)vs › | $1.83B | 0.01% | N/A | N/A | N/A |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.60B | 0.12% | N/A | N/A | N/A |
Debt/Assets
25.8%
Debt/Equity
1.25
Current Ratio
1.70
Interest Coverage
0.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 25.84% |
| 2026-03-31 | 26.15% |
| 2025-12-31 | 30.93% |
| 2025-09-30 | 29.90% |
| 2025-06-30 | 32.96% |
| 2025-03-31 | 36.79% |
| 2024-12-31 | 42.10% |
| 2024-09-30 | 31.81% |
| 2024-06-30 | 30.70% |
| 2024-03-31 | 26.92% |
| 2023-12-31 | 28.86% |
| 2023-09-30 | 22.17% |
| 2023-06-30 | 21.77% |
| 2023-03-31 | 21.48% |
| 2022-12-31 | 25.97% |
| 2022-09-30 | 21.24% |
| 2022-06-30 | 23.90% |
| 2022-03-31 | 24.49% |
| 2021-12-31 | 24.98% |
| 2021-09-30 | 23.86% |
| 2021-06-30 | 23.27% |
| 2021-03-31 | 22.86% |
| 2020-12-31 | 45.62% |
